Lasa Supergenerics advanced 3.63% to Rs 60 after the company announced the receipt of new orders worth Rs 50 crore from 5 customers.
Dr. Omkar Herlekar, chairman & managing director, Lasa Supergenerics, said: "We are looking forward to receive such bulk orders from overseas customers in near future.
Moreover, we are working in making all our products fully backward integrated which shall boost return on capital of the company, we shall continue to remain committed to growth."
Lasa Supergenerics is a vertically integrated group spanning the entire veterinary, animal, and human healthcare value chain-from discovery to delivery, with established credentials in research, manufacturing, and global marketing.
The company's net profit surged to Rs 12.28 crore in Q4 FY22 from Rs 3.79 crore in Q4 FY21. Revenue from operations increased by 31% YoY to Rs 51.21 crore during the quarter.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU